IOL Chemicals and Pharmaceuticals Ltd
NSE:IOLCP

Watchlist Manager
IOL Chemicals and Pharmaceuticals Ltd Logo
IOL Chemicals and Pharmaceuticals Ltd
NSE:IOLCP
Watchlist
Price: 65.51 INR -0.71% Market Closed
Market Cap: 19.2B INR

IOLCP's latest stock split occurred on Mar 11, 2025

The company executed a 5-for-1 stock split, meaning that for every share held, investors received 5 new shares.

Before the split, IOLCP traded at 69.12 per share. Afterward, the share price was about 65.35.

The adjusted shares began trading on Mar 11, 2025. This was the only stock split in IOLCP's history.

Last Splits:
Mar 11, 2025
5-for-1
Pre-Split Price
69.12 69.12
Post-Split Price
65.35
Before
After
Last Splits:
Mar 11, 2025
5-for-1

IOL Chemicals and Pharmaceuticals Ltd
Stock Splits History

IOLCP Stock Splits Timeline
Mar 11, 2025
Mar 11, 2025
Split 5-for-1
x5
Pre-Split Price
69.12 69.12
Post-Split Price
65.35
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 22, 2025
Seres Therapeutics Inc
SWB:1S9
1-for-20
/20
0.3216 6.432 EUR 6.432 6.432 EUR
Apr 22, 2025
G
Golden Shield Resources Inc
F:4LE0
1-for-10
/10
0.011 0.11 EUR 0.11 0.11 EUR
Apr 22, 2025
E
EV Advanced Material Co Ltd
KOSDAQ:131400
911-for-787
x1.1575603557814
1493 1493 KRW 1439 1439 KRW
Apr 22, 2025
Seres Therapeutics Inc
F:1S9
1-for-20
/20
0.01 0.2 EUR 0.2 0.2 EUR
Apr 22, 2025
G
Golden Shield Resources Inc
OTC:GSRFF
1-for-10
/10
0.024 0.24 USD 0.24 0.24 USD
Load More

IOL Chemicals and Pharmaceuticals Ltd
Glance View

Market Cap
19.2B INR
Industry
Pharmaceuticals

IOL Chemicals & Pharmaceuticals Ltd. engages in the manufacture of organic and inorganic chemical compounds. The company is headquartered in Ludhiana, Punjab and currently employs 2,316 full-time employees. The company went IPO on 2010-11-05. The firm is engaged in manufacturing and selling of organic chemicals, specialty, intermediates, and bulk drugs. Its product portfolio covers various therapeutic categories, such as Pain Management, Anti-diabetic, Anti-hypertensive, and Anti-convulsant, amongst others. Its active pharma ingredients (API) product portfolio include Ibuprofen, Ibuprofen Lysinate, Ibuprofen Sodium, Dex-Ibuprofen, Metformin HCL, Clopidogrel Bisulphate (Form II), Pantoprazole Sodium, Fenofibrate, Gabapentin, Lamotrigine, Ursodeoxycholic Acid, Losartan Potassium and Levetiracetam. Its specialty chemical division include Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride and Mono Chloro Acetic Acid. The firm caters to the pharmaceutical and specialty chemical requirements across both domestic and international markets. The company serves Austria, Belgium, Hungry, Spain, Germany, Italy, Netherlands, Switzerland and others.

IOLCP Intrinsic Value
66.46 INR
Undervaluation 1%
Intrinsic Value
Price
Back to Top